دانلود کتاب اپیدمیولوژی دارویی (فارماکو اپیدمیولوژی)
Pharmacoepidemiology, 5ed

“This book is no surprise. The first four editions were excellent and this one continues that tradition of excellence. This is the only book on pharmacoepidemiology that anyone needs.”  (Doody’s, ۱۰ August 2012)

Contents

PART I Introduction
۱ What is Pharmacoepidemiology?, 3
۲ Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies, 23
۳ Basic Principles of Clinical Epidemiology Relevant to Pharmacoepidemiologic Studies, 38
۴ Sample Size Considerations for Pharmacoepidemiologic Studies, 52
۵ When Should One Perform Pharmacoepidemiologic Studies?, 62

PART II The Role of Pharmacoepidemiology in Different Sectors
۶ The Role of Pharmacoepidemiology in the Health-Care System and Academia, 73
۷ The Role of Pharmacoepidemiology in Industry, 84
۸ The Role of Pharmacoepidemiology in Regulatory Agencies, 107
۹ Pharmacoepidemiology and the Law, 117

PART III Sources of Data for Pharmacoepidemiologic Studies
۱۰ Postmarketing Spontaneous Pharmacovigilance Reporting Systems, 137
۱۱ Overview of Automated Databases in Pharmacoepidemiology, 158
۱۲ Health Maintenance Organizations/Health Plans, 163
۱۳ Commercial Insurance Databases, 189
۱۴ US Government Claims Databases, 209
۱۵ Medical Record Databases, 224
۱۶ In-hospital Databases, 244
۱۷ Canadian Provincial Databases, 259
۱۸ Pharmacy-based Medical Record Linkage Systems, 270
۱۹ Case–Control Surveillance, 287
۲۰ Prescription–Event Monitoring, 301
۲۱ Registries, 331
۲۲ Field Studies, 347
۲۳ How Should One Perform Pharmacoepidemiologic Studies? Choosing Among the Available Alternatives, 364

PART IV Selected Special Applications of Pharmacoepidemiology
۲۴ Studies of Drug Utilization, 379
۲۵ Evaluating and Improving Physician Prescribing, 402
۲۶ Pharmacoepidemiologic Studies of Vaccine Safety, 423
۲۷ Epidemiologic Studies of Medical Devices: Methodologic Considerations for Implantable Devices, 469
۲۸ Studies of Drug-Induced Birth Defects, 487
۲۹ Risk Management, 505
۳۰ FDA’s Sentinel Initiative: Active Surveillance to Identify Safety Signals, 534
۳۱ Pharmacoepidemiology and Pharmaceutical Reimbursement Policy, 555
۳۲ Comparative Effectiveness Research, 561

PART V Selected Special Methodologic Issues in Pharmacoepidemiology
۳۳ Assessing Causality of Case Reports of Suspected Adverse Events, 583
۳۴ Molecular Pharmacoepidemiology, 601
۳۵ Bioethical Issues in Pharmacoepidemiologic Research, 623
۳۶ The Use of Randomized Controlled Trials for Pharmacoepidemiologic Studies, 640
۳۷ The Use of Pharmacoepidemiology to Study Beneficial Drug Effects, 655
۳۸ Pharmacoeconomics: Economic Evaluation of Pharmaceuticals, 678
۳۹ Using Quality-of-Life Measurements in Pharmacoepidemiologic Research, 709
۴۰ The Use of Meta-analysis in Pharmacoepidemiology, 723
۴۱ Validity of Pharmacoepidemiologic Drug and Diagnosis Data, 757
۴۲ Studies of Medication Adherence, 795
۴۳ Risk Evaluation and Communication, 810
۴۴ Studying Effects of Antibiotics, 827
۴۵ The Pharmacoepidemiology of Medication Errors, 840
۴۶ Sequential Statistical Methods for Prospective Postmarketing Safety Surveillance, 852
۴۷ Advanced Approaches to Controlling Confounding in Pharmacoepidemiologic Studies, 868

PART VI Conclusion
۴۸ The Future of Pharmacoepidemiology, 895